Skip to main content
CRAC
NASDAQ Real Estate & Construction

SPAC Crown Reserve Announces Definitive $1.0B Merger with Carvix, Securing Financing

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
9
Price
$10.01
Mkt Cap
$172.845M
52W Low
$9.89
52W High
$10.05
Market data snapshot near publication time

Summary

Crown Reserve Acquisition Corp. I has entered into a definitive business combination agreement with Carvix, Inc., valuing Carvix at an implied enterprise value of $1.0 billion and outlining key financing and governance terms.


Key Events

  • Definitive Merger Agreement Signed

    Crown Reserve Acquisition Corp. I (SPAC) has signed a definitive Business Combination Agreement with Carvix, Inc., a technology-driven automotive platform, following the initial announcement on March 31, 2026.

  • $1.0 Billion Implied Valuation for Carvix

    The transaction values Carvix at an implied enterprise value of $1.0 billion, with existing Carvix stockholders receiving Crown Reserve common stock based on a $10.00 per share reference value.

  • Significant Financing Commitments

    The agreement includes efforts to raise a minimum of $80.0 million in PIPE financing and a $20.0 million committed equity line of credit, with a $10.0 million minimum cash condition at closing.

  • Earnout Consideration for Stockholders and Sponsor

    Carvix stockholders are eligible for up to 50,000,100 additional shares, and the Sponsor for up to 3,000,000 shares, tied to future revenue and EBITDA targets over a four-year period.


Analysis

This 8-K provides the official and detailed terms of the definitive business combination agreement between Crown Reserve Acquisition Corp. I and Carvix, Inc., following the initial news announcement on March 31, 2026. The transaction, which values Carvix at an implied enterprise value of $1.0 billion, is a critical step for the SPAC to fulfill its mandate and addresses the going concern warning disclosed in the recent 10-K. The agreement includes plans for a significant PIPE financing and an equity line of credit, crucial for the combined entity's capital structure and growth. The successful completion of this merger is essential for the company's future operations and Nasdaq listing.

At the time of this filing, CRAC was trading at $10.01 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $172.8M. The 52-week trading range was $9.89 to $10.05. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRAC - Latest Insights

CRAC
May 14, 2026, 8:13 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.08
Real-time Price: $10.11 info
Change: +$0.030 (+0.30%) info
Market Cap: $226.148M info
CRAC
Apr 03, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.01
Real-time Price: $10.11 info
Change: +$0.100 (+1.00%) info
Market Cap: $226.148M info
CRAC
Apr 01, 2026, 5:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.01
Real-time Price: $10.11 info
Change: +$0.100 (+1.00%) info
Market Cap: $226.148M info
CRAC
Mar 31, 2026, 8:11 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $10.00
Real-time Price: $10.11 info
Change: +$0.110 (+1%) info
Market Cap: $226.148M info
CRAC
Mar 27, 2026, 5:14 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $10.00
Real-time Price: $10.11 info
Change: +$0.110 (+1%) info
Market Cap: $226.148M info